Treace Medical Concepts Inc expected to post a loss of 23 cents a share - Earnings Preview

Treace Medical Concepts

06/05/2023 03:06

* Treace Medical Concepts Inc  TMCI.OQ   TMCI.O  is expected
to show a rise in quarterly revenue when it reports  results on
May 8. 
    * The Ponte Vedra Florida-based  company is expected to
report  a
35.1% increase in revenue to $39.245 million from $29.05 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Treace Medical
Concepts
Inc is for a loss of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $30​, above​ its last closing price of $26.47.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.15       -0.14      -0.08     Beat    42.9
 Sep. 30 2022  -0.29       -0.29      -0.22     Beat    23.5
 Jun. 30 2022  -0.19       -0.20      -0.31     Missed  -51.2​
 Mar. 31 2022  -0.21       -0.20      -0.16     Beat    21
 ​​Dec.        -0.01       0.00       -0.12     Missed  -2,300
 31 2021                                                
 Sep. 30 2021  -0.12       -0.12      -0.12     Met     0​
 Jun. 30 2021  -0.12       -0.12      -0.10     Beat    16.7
 Mar. 31 2021  -0.06       -0.06      -0.07     Missed  -16.7
 This summary was machine generated May 6 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated